| Human CHODL Protein (LTP10316) |
| LTP10316 |
| 100ug |
|
$383 In stock |
| chondrolectin (CHODL) is commonly overexpressed in the majority of lung cancers, indicating a possible correlation between CHODL and metastasis of lung cancer cells. the expression of CHODL is significantly decreased in HCC clinical samples and in HCC cell lines. Overexpression of CHODL in SMMC7721 cells with a lentiviral vector increased SMMC7721 cell migration and invasion. |
| Recombinant Human CHODL Protein is expressed from Expi293 with hFc tag at the C-terminal. It contains Arg22-Asn216. |
| CHODL |
| Human |
| Q9H9P2-1 |
| Arg22-Asn216 |
| The protein has a predicted MW of 48.7 kDa. Due to glycosylation, the protein migrates to 65-68 kDa based on the Tris-Bis PAGE result. |
| 0 |
| C-hFc |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| ![Human CHODL Protein (LTP10316)](/peptide-product/images/protein-products/LTP10316/20210907140209.png) |